Effect of transforming growth factor-β on osteoblast cells cultured on 3 different hydroxyapatite surfaces

被引:0
|
作者
Ong, JL
Carnes, DL
Sogal, A
机构
[1] Univ Texas, Hlth Sci Ctr, Div Biomat, Dept Restorat Mat, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Endodont, San Antonio, TX USA
[3] CeraMed Corp, Lakewood, CO USA
关键词
alkaline phosphatase activity; heat treatments; hydroxyapatite; osteocalcin concentration; transforming growth factor-beta;
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
In this study, the specific objective was to investigate the combined effect of different treatments of transforming growth factor-beta (TCF-beta) and hydroxyapatite (HA) on osteoblast response in vitro. Since the nature of bone cell responses in vitro is influenced by the properties of HA ceramics, this study was divided into 2 components: a chemical and crystallographic characterization of the HA ceramics, and an in vitro cell culture study. Sintered HA samples were observed to have the highest crystallite size, compared to as-received HA and calcined HA samples. No differences in surface roughness and chemical composition were observed between the sintered, calcined, and as-received HA surfaces. In concurrence with the x-ray diffraction, high-resolution x-ray photoelectron spectroscopy of Ca 2p also indicated a higher crystallinity on sintered HA samples compared to calcined and as-received HA samples. Protein production by osteoblast cells was not statistically different on the 3 HA surfaces in the absence of TGF-beta. However, there was a dose-dependent increase in TGF-beta-stimulated protein produc tion on the 3 different HA surfaces. As indicated by increased alkaline phosphatase-specific activity, as well as 1,25 (OH2) vitamin D-3-stimulated osteocalcin production, a more differentiated osteoblastlike phenotype was observed on the sintered HA surfaces compared to the as-received HA and calcined HA surfaces. An increased osteoblast-like cell activity on sintered HA surfaces in the presence of different TGF-beta dosage suggested that sintering of HA surfaces may play an important role in governing cellular response.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 50 条
  • [31] Lovastatin inhibit insulin-like growth factor-1 and transforming growth factor-β, expression on cultured mesangial cells
    Liu, C
    Yang, T
    Chen, JW
    DIABETES, 2002, 51 : A512 - A512
  • [32] Intracellular processing of transforming growth factor-β in mesangial cells
    Ceol, M
    Vianello, D
    Baggio, B
    Meani, A
    Schleicher, E
    Anglani, F
    Gambaro, G
    RENAL FAILURE, 1998, 20 (02) : 361 - 369
  • [33] Transforming growth factor-β in stem cells and tissue homeostasis
    Xin Xu
    Liwei Zheng
    Quan Yuan
    Gehua Zhen
    Janet L. Crane
    Xuedong Zhou
    Xu Cao
    Bone Research, 6
  • [34] Transforming growth factor-β in stem cells and tissue homeostasis
    Xin Xu
    Liwei Zheng
    Quan Yuan
    Gehua Zhen
    Janet LCrane
    Xuedong Zhou
    Xu Cao
    Bone Research, 2018, (01) : 1 - 31
  • [35] Transforming growth factor-β in stem cells and tissue homeostasis
    Xin Xu
    Liwei Zheng
    Quan Yuan
    Gehua Zhen
    Janet L.Crane
    Xuedong Zhou
    Xu Cao
    Bone Research, 2018, 6 (01) : 1 - 31
  • [36] Transforming growth factor-β signaling in stem cells and cancer
    Mishra, L
    Derynck, R
    Mishra, B
    SCIENCE, 2005, 310 (5745) : 68 - 71
  • [37] Transforming growth factor-β signaling in Anopheles mosquito cells
    Mondal, SP
    George, M
    Luckhart, S
    FASEB JOURNAL, 2006, 20 (05): : A983 - A984
  • [38] Transforming growth factor-β signal transduction in epithelial cells
    Yue, JB
    Mulder, KM
    PHARMACOLOGY & THERAPEUTICS, 2001, 91 (01) : 1 - 34
  • [39] Transforming growth factor-β in stem cells and tissue homeostasis
    Xu, Xin
    Zheng, Liwei
    Yuan, Quan
    Zhen, Gehua
    Crane, Janet L.
    Zhou, Xuedong
    Cao, Xu
    BONE RESEARCH, 2018, 6
  • [40] Transforming growth factor-β signaling and regulatory T cells
    Ferretti, Gianluigi
    Felici, Alessandra
    Cognetti, Francesco
    Mandala, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4695 - 4696